Selected Papers from CUBANNI 2017—“The Fourth International Workshop of Neuroimmunology”

Selected Papers from CUBANNI 2017—“The Fourth International Workshop of Neuroimmunology” PDF Author: Maria De los Angeles Robinson Agramonte
Publisher: MDPI
ISBN: 3038974870
Category : Education
Languages : en
Pages : 171

Get Book Here

Book Description
This book is a printed edition of the Special Issue "Selected Papers from CUBANNI 2017—“The Fourth International Workshop of Neuroimmunology” " that was published in Behavioral Sciences

Selected Papers from CUBANNI 2017—“The Fourth International Workshop of Neuroimmunology”

Selected Papers from CUBANNI 2017—“The Fourth International Workshop of Neuroimmunology” PDF Author: Maria De los Angeles Robinson Agramonte
Publisher: MDPI
ISBN: 3038974870
Category : Education
Languages : en
Pages : 171

Get Book Here

Book Description
This book is a printed edition of the Special Issue "Selected Papers from CUBANNI 2017—“The Fourth International Workshop of Neuroimmunology” " that was published in Behavioral Sciences

Selected Papers from CUBANNI 2017-"The Fourth International Workshop of Neuroimmunology"

Selected Papers from CUBANNI 2017- Author: Dario Siniscalco
Publisher:
ISBN: 9783038974888
Category : Electronic books
Languages : en
Pages : 1

Get Book Here

Book Description
In parallel with a decrease/stabilization in the use of internationally controlled drugs, the market of novel psychoactive substances (NPS) continues increasing, year after year, with the Internet playing a pivotal role in contributing to this complex scenario. At times, although misleading, the terms 'legal highs' or 'research chemicals' have been used to describe these molecules. Overall, about 5% of 19-24-year-old European people have already experimented with them, because both NPS' intense psychoactive effects and their virtual non-detectability in routine drug screenings. Although 'novel' typically refers to molecules that have recently become a reason of current/potential public health concern, at times, the NPS scenario may indeed focus on pharmaceutical molecules. These may have either not entered the market, or are currently prescribed, with their potential for misuse resulting from the relating high dosages/idiosyncratic ways of self-administration. A concurrent use of a range of different NPS, and/or medications, is frequently being reported and this may be a reason of further clinical complications. Given their complex pharmacodynamics, there are increasing levels of concern about the onset of acute/chronic psychopathological associated with NPS intake. This Special Issue aims at providing an overview of a range of NPS-related issues, e.g., preclinical, epidemiological, and clinical pharmacological; the medical and psychopathological consequences associated with their intake; and, finally, the analytical chemistry and forensic analysis challenges associated with the NPS phenomenon.

Cannabis

Cannabis PDF Author: Marco Colizzi
Publisher: MDPI
ISBN: 3039439952
Category : Science
Languages : en
Pages : 204

Get Book Here

Book Description
Over the years, there has been increasing interest into the public health impact of cannabis use, especially by young adults. This follows the evidence of a growing prevalence of regular cannabis use worldwide, with approximately 200 million users. Recreational cannabis use, especially a frequent use of products with high levels of its main psychoactive ingredient delta-9-tetrahydrocannabinol (Δ 9-THC), can cause dependence and have transient and long-lasting detrimental mental health effects, also negatively impacting cognitive processing and brain function and metabolism. In regular users, the development of tolerance to some of the effects of cannabis, especially the pleasurable ones, may lead to progressively heavier use in order to obtain the same effects in terms of their intensity, with higher health risks. However, the Cannabis Sativa plant contains different chemicals with different potential effects. In this regard, cannabidiol has gained interest because of its potential therapeutic properties, in line with evidence that CBD and Δ9-THC may exhibit opposite effects at the cannabinoid receptor type 1 (CB1), Δ9-THC being a partial agonist and CBD an antagonist/inverse agonist. Different cannabinoids may modulate human brain function and behavior in different ways, with different risk–benefit profiles.

Risk Factors for Psychosis

Risk Factors for Psychosis PDF Author: Andrew Thompson
Publisher: Academic Press
ISBN: 0128132027
Category : Psychology
Languages : en
Pages : 458

Get Book Here

Book Description
Risk Factors for Psychosis: Paradigms, Mechanisms, and Prevention combines the related, but disparate research endeavors into a single text that considers all risk factors for psychosis, including biological, psychological and environmental factors. The book also introduces the ethics and current treatment evidence that attempts to ameliorate risk or reduce the number of individuals with risk factors developing a psychotic disorder. Finally, the book highlights new research paradigms that will further enhance the field in the future. Psychotic disorders affect more than 50 million people worldwide, creating a devastating effect on lives and causing major financial and emotional impact on families and on society as a whole. The search for risk factors for psychosis has developed rapidly over the past decades, invigorated by changes in the thinking about the malleability and treatability of psychotic disorders. The paradigms for investigating psychosis risk have developed, often in parallel, but there has been no book to date that has summarized and synthesized the current approaches. - Integrates research from biological, psychological and environmental factors into a single resource - Offers insight into at-risk paradigms, biomarkers, and the current state of research on treatment option for psychosis - Presents a holistic and dynamic look at risk syndromes and how they can be measured through neuroimaging, neuropsychology and other methods